Year Ended
Registration number:
Kingsley Healthcare Limited
Contents
Strategic Report |
|
Directors' Report |
|
Statement of Directors' Responsibilities |
|
Independent Auditor's Report |
|
Statement of Income and Retained Earnings |
|
Balance Sheet |
|
Notes to the Financial Statements |
Kingsley Healthcare Limited
Strategic Report for the Year Ended 30 September 2024
The Directors present their report for the year ended 30 September 2024.
The Kingsley Healthcare Group (“Kingsley”) can be defined as the ten operating groups headed by the following companies: Peacock Holdings (2015) Limited; KCH (UK) Holdings Limited; Regal Healthcare Holdings Limited; Althea Healthcare Holdings Limited; Timperley Holdings Limited; Hestia Healthcare Holdings Limited; Partington Healthcare Holdings Limited; Kingsley Healthcare (OLH) Limited; Kingsley Healthcare (Bournemouth Property) Limited and Kingsley (KMT) Limited. All of these operating groups under the Kingsley umbrella are affected by similar factors and, therefore, the same strategies, which are covered in this Strategic Report, apply to each of them. For the purpose of these specific financial statements, meanwhile, references to the “Group” will refer to the KCH (UK) Holdings Limited operating group whilst references to the “Company” will refer to Kingsley Healthcare Limited itself.
Kingsley Healthcare
Kingsley Healthcare, a nationally recognised, family-run provider of residential and nursing care, proudly reports a year of continued progress and resilience, underpinned by strong trading performance, robust cash generation and a clear strategic vision. Kingsley Healthcare continues to be a leader in the adult social care sector through its long-term investment approach, people-first culture and sustained operational excellence.
As the UK’s first major care operator to achieve B Corp certification and having been named Residential Care Provider of the Year – 2024 by Health Investor, we remain steadfast in our commitment to delivering high-quality, person-centred care and driving meaningful social and environmental impact across our operations.
Strategic Focus and Business Performance
Our strategy centres on harnessing the strength of our balance sheet and the depth of our talent to drive both organic and inorganic growth. Mature homes within the Kingsley portfolio continue to deliver strong revenue growth and profitability, with overall trading performance aligned to expectations.
Significant cash generation during the period enabled Kingsley to secure additional banking facilities, enhancing our financial flexibility to support further investment in services, property, technology and people. These developments reaffirm our long-term commitment to creating value for all stakeholders.
Operational Developments and Investments:
We continue to make targeted investments to future-proof the business, including:
• |
Expansion into new geographic hubs, supported by robust infrastructure and internal capabilities. |
• |
Investment in digital transformation, covering call centre operations, integrated finance systems, cyber security and IT infrastructure. |
• |
Enhancements to core care platforms — including care planning, medication management and governance systems. |
• |
Implementation of a comprehensive CRM solution to strengthen sales, client engagement and operational efficiency. |
Kingsley Healthcare Limited
Strategic Report for the Year Ended 30 September 2024
Sustainability and Corporate Responsibility
Kingsley’s recognition as a B Corp certified organisation marks a milestone in our sustainability journey. We have embedded sustainability into all areas of our service delivery, focusing on community wellbeing, environmental stewardship and responsible governance.
People and Culture
Our people remain at the heart of our success. We have invested substantially in training and development through the Kingsley Academy, ensuring every one of our front line colleagues is equipped to deliver high-quality, compassionate care.
We are proud to be a Real Living Wage Employer, with low staff turnover rates in the sector. Independent platforms such as Glassdoor and Indeed consistently rank Kingsley as one of the top employers in healthcare for workplace wellbeing.
We have increased our use of social media as a platform to showcase the outstanding care and community engagement within our homes. This not only bolsters staff recognition and morale, but also strengthens our brand as an employer and helps families stay connected with daily life within our services.
Kingsley Healthcare Limited
Kingsley Healthcare Limited is a holding company within the KCH (UK) Holdings Limited Group. The company owns shares in subsidiary entity, Kingsley Care Homes Limited which operates six care facilities across the East of England, providing high quality residential, nursing and specialist care.
Principal activity
The principal activity of the company is that of residential care for the elderly.
Fair review of the business
When analysing Kingsley Healthcare Limited’s trading results for the financial year to 30 September 2024, the Company’s board is pleased with its performance when compared to previous years.
As with prior year the Company’s net loss before tax of the year of £170,995 (2023 - £147,872) can be attributed entirely to financing costs.
The Company’s Fixed Assets amount to £5m whilst Net Debt totals £0.02m, excluding intercompany debt.
This places the Company in a very strong position within its industry in the post-pandemic era.
Key performance indicators
In keeping with previous year-end reporting, the trading Company has measured its success during the 2024 financial year against a key performance indicators. The benchmarks is centred on results in the areas of net profit.
2024 |
2023 |
|
Net Profit/ (Loss) Before Tax |
(£170,995) |
(£147,872) |
Kingsley Healthcare Limited
Strategic Report for the Year Ended 30 September 2024
Section 172(1) Statement
The Directors of the Company are required to act in accordance with the duties prescribed under Section 172 of the Companies Act 2006, which demands they should carry out their duties in a way they consider, in good faith, to be most likely to promote the success of the Company for the benefit of its members as a whole while having regard to the interests of the Company’s other stakeholders. The Company includes among its other primary stakeholders its staff, its service users and their families, its suppliers, its financing partners, the relevant industry regulators and the communities the Company serves. It is these parties that either impact the Group’s strategy materially or are themselves impacted by it directly. As a responsible business building long-term shareholder value, we listen to our stakeholders regularly to help us guide our strategy and to ensure we continue to operate in a way that delivers the best care we are able to provide to our residents.
Section 172 requires each director of a company, when making decisions regarding the like of the Company’s trading strategy and operational objectives, to ensure that such decisions are made considering the possible long-term consequences associated with them. For its part, and in pursuit of the realisation of its ‘Vision 2025’ strategy during the year, the Board has regularly monitored progress against its targets and modified its ambitions to ensure predicted outcomes result in the ongoing sustainability of the business. The board of the Company consistently maintains a long-term outlook in relation to its future activities through many different aspects of the business, whether it is the investment in current and future facilities, staff recruitment and retention or compliance and risk management, Kingsley has ensured the long-term effect is incorporated with every decision.
The Board recognises the importance of the responsibilities incumbent upon it under Section 172 and believes it has made all material decisions during the course of the year in a manner that reflects its proper consideration of these duties. In doing so, the Board has consistently behaved responsibly towards its shareholders to ensure they are treated fairly and equally.
The Company maintains open and regular communication with its financing partners, providing detailed management accounts and long-term financial models to ensure transparency and alignment.
The Company places utmost importance on the dignity, independence, and well-being of its service users. Central to all Company endeavours are the quality of daily experiences for these stakeholders. The Directors emphasize the crucial role of maintaining good governance across the organisation's activities, ensuring consistency for all involved parties. Setting itself apart from competitors, the Company upholds high standards of integrity and business conduct, driven by values of kindness, compassion and empathy.
The Company has maintained a steady supply of essential operational materials by fostering strong, long-term partnerships with trusted suppliers. Many of these suppliers have prioritised their longstanding relationship with Kingsley over new business opportunities, offering key advantages such as stable pricing and access to warehouse facilities. As supply chain pressures continue into 2025, we remain committed to strengthening these invaluable relationships.
Understanding that our homes are often central to their communities, Kingsley takes its responsibilities seriously. Our senior leadership team actively champions initiatives that support the well-being of the towns and villages we serve. Beyond our dedication to responsible energy management and efficiency, we have expanded our efforts with new community-focused initiatives across our locations.
Our people are at the heart of everything we do. We deeply value each colleague’s contribution to upholding Kingsley’s values and driving our success. To reflect our commitment, we have conducted a thorough review of our benefits package, ensuring we remain the leading employer in adult social care across all our home locations.
Kingsley Healthcare Limited
Strategic Report for the Year Ended 30 September 2024
In 2024, Kingsley reaffirmed its commitment as a Real Living Wage employer. We believe that fair pay not only acknowledges our employees' dedication but also strengthens retention and attracts top talent. In an industry where rising living costs and workforce shortages present challenges, it is crucial to demonstrate our unwavering support for our team. Beyond ensuring the Real Living Wage as a baseline, we provide additional resources, including financial guidance, well-being programs, mental health support, and nutrition counselling, ensuring our people feel valued, supported and empowered.
Kingsley proactively continues to invest in new platforms to support its staff with their career and personal progression. Since the year end, one of the most notable achievements has been the successful implementation of Workday, a comprehensive financial accounting and reporting system. While this transition demanded considerable effort and resources, the results are clear and we now enjoy faster, more streamlined processes that enable our leadership team to focus on delivering innovative care. With integrated AI and machine learning capabilities, these systems offer data-driven insights that will help Kingsley further enhance its efficiency and service quality.
As a leading national provider of residential, nursing, and specialist care services, we have an inherent duty to be a dependable support system for those who rely on us—our residents, colleagues, and partners alike. We take this responsibility seriously and our stakeholder management approach is built on fostering strong, mutually beneficial relationships grounded in integrity, compassion and kindness. These core values are woven into every aspect of our organisation, setting Kingsley apart as the trusted and respected provider it is today.
Looking ahead, we are confident that the financial year ending 30 September 2024 has been tremendously positive, marked by our continued commitment to delivering exceptional care while advancing the aspirations of our stakeholders. The Board remains focused on making strategic, long-term investment decisions that prioritise the well-being of all those we serve.
Environmental, Social & Governance (ESG)
As noted above, achieving B Corp certification represents a key milestone in our sustainability journey. We have integrated sustainability across all aspects of our service delivery framework, with a focus on community wellbeing, environmental responsibility and strong governance.
Principal risks and uncertainties
Sector and Market Risk
The UK care sector benefits from favourable demographic trends but faces constraints in capacity due to rising building costs and planning limitations. We have proactively invested in our property portfolio to ensure that our homes remain modern, efficient and aligned with evolving customer expectations.
There remains a strong demand for high quality care from self-funding clients, complemented by stable relationships with local commissioning bodies, supported by transparent cost of care models.
Operational and Regulatory Risk
The care sector is subject to extensive regulatory oversight, which means non-compliance can lead to both reputational damage, limitations on admissions and even the closure of services.
Our compliance teams work in close coordination with our operational teams to ensure all regulatory standards are met and our governance framework remains strong. Where improvements are required, comprehensive action plans are put in place.
Kingsley Healthcare Limited
Strategic Report for the Year Ended 30 September 2024
People Risk
Sector-wide workforce shortages, high turnover and reliance on agency staff can impact the quality of care and operational continuity.
Our strategic focus on staff retention, remuneration and wellbeing mitigates the wider sector challenge of staffing shortages. Immigration changes present only a limited risk, given our strong domestic workforce and low reliance on overseas recruitment.
Financial and Funding Risk
Exposure to interest rate volatility, funding constraints or regional property value fluctuations could impact our financial performance and growth plans.
We maintain strong relationships with our banking partners and have once again secured long-term facilities, during the year, that support both ongoing operations and future expansion. Our advisory committee is constantly monitoring interest rate volatility, bond rates and hedging movements. We are pleased that, given the strength of our balance sheet, these are managed in a sensible manner. Our diversified property portfolio mitigates location-specific risks.
Going Concern
The Directors have reviewed the Group’s trading projections, cash flow forecasts and financial plans for the foreseeable future and confirm that the Group has significant resources that are more than adequate to allow it to meet its obligations for a period of twelve months from the signing of these accounts. With a robust balance sheet, growing revenues and resolute banking support, the Directors are confident in the Group’s ongoing viability.
As such, the Directors consider it appropriate to prepare these financial statements on a going concern basis.
We remain confident in the strength and resilience of our business model. Meanwhile, our continued investment in infrastructure, digital systems, talent and real property positions Kingsley Healthcare for sustained growth and leadership in the care sector.
The Directors are cautiously optimistic about the sector’s long-term prospects and have confidence in Kingsley’s unique ability, as a family-owned operator, to respond with agility and purpose to emerging opportunities.
We will continue to invest in our services, expand our reach and enrich the lives of those we serve, being always guided by our core values of integrity, kindness, compassion and empathy.
Approved and authorised by the
......................................... |
Kingsley Healthcare Limited
Directors' Report for the Year Ended 30 September 2024
The directors present their report and the financial statements for the year ended 30 September 2024.
Directors of the company
The directors who held office during the year were as follows:
Financial instruments
Objectives and policies
The directors make use of a range of financial resources to further the operation and development of the Company’s business. Secured senior debt facilities are provided, on an approximately equal basis, by three well established and highly regarded banks. The Company continues to believe that its working partnership with these institutions appropriately diversifies its counterparty risk and the failure of one or other of the Company’s banking partners is deemed to be very unlikely.
The Company’s capital expenditure and working capital requirements are funded by a blend of secured term loans and overdraft facilities, which are secured against the Company’s property assets. The directors monitor debt servicing capability and covenant compliance on an ongoing basis, utilising three-year financial forecasts to ensure adequacy in these areas.
Certain of the Company’s future development projects, including several that have been recently initiated, will feature funding arrangements with a prominent real estate investment trust that specialises in providing sustainable support for operators in the healthcare sector. The directors recognise that it is largely down to the financial strength and historic performance of the Company that
it has been able to maintain a strong negotiating position in this context. They are also confident that the Company’s relationship with its funding partners continues to be stable and productive.
Price risk, credit risk, liquidity risk and cash flow risk
The directors believe that the Company’s diversification of its service offering across a range of geographical locations nationally provides fundamental protection against price risk in relation to its fixed asset investment portfolio. The recent appointment of a dedicated Credit Controller, meanwhile, has bolstered the Company’s capability in the area of debt collection and income management across both the privately-funded and local authority-funded market segments. Bad debts remain at minimal levels and electronic fee processing provides for efficient and timely settlement of issued invoices.
Management accounting information is carefully collated and delivered to the board on a monthly basis, which allows the directors to accurately monitor the Company’s cash flow position and mitigate any risk in this critical operating space.
Kingsley Healthcare Limited
Directors' Report for the Year Ended 30 September 2024
Disclosure of information to the auditors
Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.
Disclosure Requirements
In accordance with Section 414C(11) of the Companies Act 2006, the directors have chosen to include certain disclosures in the Strategic Report that would otherwise be required in the Directors’ Report. These include:
• An indication of the company’s future developments;
• Information on the company’s engagement with employees and stakeholders;
• Details of the company’s environmental, social, and governance (ESG) initiatives, including its B Corp certification.
The directors believe that including this information in the Strategic Report provides a more cohesive and comprehensive overview of the company’s strategy, performance, and impact.
Reappointment of auditors
The auditors PKF Francis Clark are deemed to be reappointed under section 487(2) of the Companies Act 2006.
Approved and authorised by the
......................................... |
Kingsley Healthcare Limited
Statement of Directors' Responsibilities
The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
• |
select suitable accounting policies and apply them consistently; |
• |
make judgements and accounting estimates that are reasonable and prudent; |
• |
state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and |
• |
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Kingsley Healthcare Limited
Independent Auditor's Report to the Members of Kingsley Healthcare Limited
Opinion
We have audited the financial statements of Kingsley Healthcare Limited (the 'company') for the year ended 30 September 2024, which comprise the Statement of Income and Retained Earnings, Balance Sheet, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
• | give a true and fair view of the state of the company's affairs as at 30 September 2024 and of its loss for the year then ended; |
• | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
• | have been prepared in accordance with the requirements of the Companies Act 2006. |
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information
The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Kingsley Healthcare Limited
Independent Auditor's Report to the Members of Kingsley Healthcare Limited
Opinion on other matter prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
• |
the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
• |
the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements. |
Matters on which we are required to report by exception
In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
• | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
• | the financial statements are not in agreement with the accounting records and returns; or |
• | certain disclosures of directors' remuneration specified by law are not made; or |
• | we have not received all the information and explanations we require for our audit. |
Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page 8, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor Responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Kingsley Healthcare Limited
Independent Auditor's Report to the Members of Kingsley Healthcare Limited
As part of our audit planning, through discussions with management, we obtained an understanding of the legal and regulatory framework that is applicable to the company and the sector in which it operates to identify the key laws and regulations affecting the company.
The key laws and regulations we identified were those that have a direct impact on the preparation of the financial statements, primarily the Companies Act 2006, the reporting framework (FRS 102), and relevant tax compliance regulations in the UK.
We discussed with management how the compliance with these laws and regulations is monitored and we discussed the policies and procedures in place. We also identified the individuals who have responsibility for ensuring that the entity complies with laws and regulations and deals with reporting any issues if they arise. As part of our planning procedures, we assessed the risk of any non-compliance with laws and regulations on the company's ability to continue trading and the risk of material misstatement to the accounts.
Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Our procedures involved the following:
- Enquiries of management and those charged with governance regarding their knowledge of any non-compliance with laws and regulations that could affect the financial statements;
As part of our enquiries, we discussed with management whether there have been any known instances, allegations or suspicions of fraud, of which there were none.
We also evaluated the risk of fraud through management override including that arising from management's incentives. The key risk we identified was fraudulent financial reporting to meet the companies bank loan covenants.
In response to the identified risk, as part of our audit work we:
- Reviewed estimates and judgements made in the accounts for any indication of bias and challenged assumptions used by management in making the estimates.
- Reviewed the basis of costs recharged between group companies making sure that there is a clear justification. We challenged management and assessed the reasonableness of all recharges.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate omissions, collusion, forgery, misrepresentations, or the override of internal controls. We are also less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Kingsley Healthcare Limited
Independent Auditor's Report to the Members of Kingsley Healthcare Limited
Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
......................................
Melville Building East
Unit 18, 23 Royal William Yard
Devon
PL1 3GW
Kingsley Healthcare Limited
Statement of Income and Retained Earnings
Year Ended 30 September 2024
Note |
2024 |
2023 |
|
Turnover |
- |
- |
|
Operating profit/(loss) |
- |
- |
|
Other interest receivable and similar income |
|
|
|
Interest payable and similar charges |
( |
( |
|
(170,995) |
(147,872) |
||
Loss before tax |
( |
( |
|
Taxation |
|
|
|
Loss for the financial year |
( |
( |
|
Retained earnings brought forward |
2,814,306 |
2,896,882 |
|
Retained earnings carried forward |
2,718,592 |
2,814,306 |
Kingsley Healthcare Limited
Balance Sheet
30 September 2024
Note |
2024 |
2023 |
|
Fixed assets |
|||
Investments |
|
|
|
Current assets |
|||
Debtors (including £263,636 due after more than one year (2023 - £134,875)) |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
- |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Profit and loss account |
|
|
|
Shareholders' funds |
|
|
Approved and authorised by the
......................................... |
......................................... |
Company Registration Number: 06499955
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
General information |
The business address is the same as the registered office address, although the entity operates care homes across various locations in England.
The address of its registered office is:
The company is a private company limited by share capital, incorporated in England and Wales.
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. There are no material departures from FRS102.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Further information about the trading situation of the company can be found in the group accounts.
Summary of disclosure exemptions
FRS 102 grants a qualifying entity exemptions from the full requirements of FRS102. The following exemptions have been taken in these financial statements as the company is deemed to be a qualifying entity.
The company has taken advantage of the exemption, under FRS102 paragraph 1.12(b), from preparing a Statement of Cash Flows on the basis that it is a qualifying entity and its ultimate parent company, KCH (UK) Holdings Limited, included the company's cash flows in its own consolidated financial statements. The company is also taking exemption from disclosure of key management personnel compensation and exemption from disclosure of related party transactions entered into between the company and other members of the KCH (UK) Holdings Limited group.
Name of parent of group
These financial statements are consolidated in the financial statements of KCH (UK) Holdings Limited.
The financial statements of KCH (UK) Holdings Limited may be obtained from Companies House.
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Group accounts not prepared
The company is exempt under section 400 of the Companies Act 2006 from the requirement to prepare consolidated financial statements as it and its subsidiary undertakings are included by full consolidation in the consolidated financial statements of its parent, KCH (UK) Holdings Limited, a company incorporated in England and Wales.
Key accounting judgements and sources of estimation uncertainty
In the application of the company's accounting policies management is required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
The key estimates that have a significant effect on the amounts recognised in the financial statements are described below:
Group recharges
Cost re-allocations are required in order to fairly reflect the cost of management services borne by group companies and entities under common control. These are based on judgemental estimates of the proportion of management time spent in areas of the business which are different from where the payroll cost is originally processed, and where joint contracts of employment are in place.
Intercompany loan interest
The business trades as part of a group. In addition to recharges of central costs and other trading settlements, management charges are raised to reflect the cost of funding arranged at a group level. Significant balances with group and other connected parties arise, these balances are due after more than one year. The lending company charges interest on these loans using a market rate for an equivalent third party loan.
The carrying value of amounts owed to/from group companies and entities under common control can be found in note 9 and 11.
Management are required to make estimates as to the outflow of economic benefits which will be required to settle an obligation in making provisions.
Tax
Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Investments
Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment. Dividends on equity securities are recognised in income when receivable.
Financial instruments
Classification
• Loans with group companies and entities under common control; and
• Cash and bank balances.
All financial instruments are classified as basic.
Recognition and measurement
Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.
Except for loans with group companies and entities under common control, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.
Loans with group companies and entities under common control are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method.
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Auditor's remuneration |
2024 |
2023 |
|
Audit of the financial statements |
|
|
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Other interest receivable and similar income |
2024 |
2023 |
|
Interest on loans to entities under common control |
|
|
Interest payable and similar expenses |
2024 |
2023 |
|
Interest expense on other finance liabilities |
- |
|
Interest payable on loans from group undertakings |
183,534 |
147,872 |
|
|
Taxation |
Tax charged/(credited) in the profit and loss account
2024 |
2023 |
|
Current taxation |
||
UK corporation tax |
( |
( |
UK corporation tax adjustment to prior periods |
( |
( |
(75,281) |
(65,296) |
The tax on profit before tax for the year is lower than the standard rate of corporation tax in the UK (2023 - higher than the standard rate of corporation tax in the UK) of
The differences are reconciled below:
2024 |
2023 |
|
Loss before tax |
( |
( |
Corporation tax at standard rate |
( |
( |
Decrease in UK and foreign current tax from adjustment for prior periods |
( |
( |
Total tax credit |
( |
( |
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Investments |
2024 |
2023 |
|
Investments in subsidiaries |
|
|
Subsidiaries |
£ |
Cost or valuation |
|
At 1 October 2023 |
|
Provision |
|
Carrying amount |
|
At 30 September 2024 |
|
At 30 September 2023 |
|
Details of undertakings
Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:
Undertaking |
Registered office |
Holding |
Proportion of voting rights and shares held |
|
2024 |
2023 |
|||
Subsidiary undertakings |
||||
|
Kingsley House, Clapham Road South, Lowestoft, Suffolk, England, NR32 1QS |
|
|
|
Subsidiary undertakings |
Kingsley Care Homes Limited The principal activity of Kingsley Care Homes Limited is |
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Debtors |
2024 |
2023 |
|
Amounts due from group undertakings |
|
|
|
|
|
Less non-current portion |
( |
( |
- |
- |
Details of trade and other debtors
£263,636 (2023 - £134,875) of amounts owed by group undertakings is classified as non current.
Cash and cash equivalents |
2024 |
2023 |
|
Cash at bank |
|
|
Creditors |
2024 |
2023 |
|
Due within one year |
||
Other creditors |
|
- |
Due after one year |
||
Amounts owed to group undertakings |
|
|
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Share capital |
Allotted, called up and fully paid shares
2024 |
2023 |
|||
No. |
£ |
No. |
£ |
|
|
|
664 |
|
664 |
Financial commitments, guarantees and contingencies |
The company is party to a cross guarantee with companies under common control in favour of Coutts & Co. The bank borrowings are secured by a charge over the freehold properties owned by the group companies.
The bank borrowing of the companies at the balance sheet date amounted to:
Parent company and fellow subsidiaries £43,828,853 (2023 - £24,378,265)
Other related parties £4,534,543 (2023 - £15,961,847)
Related party transactions |
The company has taken advantage of the exemption provided by FRS 102 to not disclose transactions entered in to between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member.
Summary of transactions with entities under common control
Loans to related parties
2023 |
Entities under common control |
Total |
Advanced |
|
|
Repaid |
( |
( |
At end of period |
- |
- |
|
Terms of loans to related parties
Kingsley Healthcare Limited
Notes to the Financial Statements
Year Ended 30 September 2024
Relationship between entity and parents |
The parent of the smallest group in which these financial statements are consolidated is
The address of KCH (UK) Holdings Limited is:
Clapham Road South
Lowestoft
Suffolk
NR32 1QS